
    
      To address the possibility that inhalation of loxapine may have adverse pulmonary effects, we
      studied two 10-mg inhaled doses of loxapine or placebo were given 10 hr apart to subjects
      with chronic obstructive pulmonary disease (COPD). The objective was to determine the time
      course and reversibility of pulmonary effects for inhaled loxapine compared with placebo.
    
  